301 related articles for article (PubMed ID: 23400582)
1. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.
Chen M; Su W; Lin X; Guo Z; Wang J; Zhang Q; Brand D; Ryffel B; Huang J; Liu Z; He X; Le AD; Zheng SG
Arthritis Rheum; 2013 May; 65(5):1181-93. PubMed ID: 23400582
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
4. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Gonzalo-Gil E; Pérez-Lorenzo MJ; Galindo M; Díaz de la Guardia R; López-Millán B; Bueno C; Menéndez P; Pablos JL; Criado G
Arthritis Res Ther; 2016 Apr; 18():77. PubMed ID: 27036118
[TBL] [Abstract][Full Text] [Related]
5. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment.
Sun Y; Kong W; Huang S; Shi B; Zhang H; Chen W; Zhang H; Zhao C; Tang X; Yao G; Feng X; Sun L
Clin Exp Rheumatol; 2017; 35(2):288-295. PubMed ID: 28094754
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
[TBL] [Abstract][Full Text] [Related]
7. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
Chen L; Wu X; Zhong J; Li D
BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
[TBL] [Abstract][Full Text] [Related]
8. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model.
Lin Y; Cheng Z; Zhong Y; Zhao Y; Xiang G; Li L; Tian L; Liu Z
J Transl Med; 2024 Mar; 22(1):305. PubMed ID: 38528553
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells.
Park KH; Mun CH; Kang MI; Lee SW; Lee SK; Park YB
Cell Transplant; 2016; 25(6):1057-72. PubMed ID: 25853338
[TBL] [Abstract][Full Text] [Related]
12. CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function.
Lee JJ; Jeong HJ; Kim MK; Wee WR; Lee WW; Kim SU; Sung C; Yang YH
Purinergic Signal; 2014; 10(2):357-65. PubMed ID: 24043462
[TBL] [Abstract][Full Text] [Related]
13. Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis.
Luo Y; Wu W; Gu J; Zhang X; Dang J; Wang J; Zheng Y; Huang F; Yuan J; Xue Y; Fu Q; Kandalam U; Colello J; Zheng SG
EBioMedicine; 2019 May; 43():620-631. PubMed ID: 31076346
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis.
Ma D; Xu K; Zhang G; Liu Y; Gao J; Tian M; Wei C; Li J; Zhang L
Int Immunopharmacol; 2019 Sep; 74():105687. PubMed ID: 31295689
[TBL] [Abstract][Full Text] [Related]
16. Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis.
Toupet K; Maumus M; Luz-Crawford P; Lombardo E; Lopez-Belmonte J; van Lent P; Garin MI; van den Berg W; Dalemans W; Jorgensen C; Noël D
PLoS One; 2015; 10(1):e0114962. PubMed ID: 25559623
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
[TBL] [Abstract][Full Text] [Related]
18. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.
Lim JY; Im KI; Lee ES; Kim N; Nam YS; Jeon YW; Cho SG
Sci Rep; 2016 Jun; 6():26851. PubMed ID: 27246365
[TBL] [Abstract][Full Text] [Related]
19. Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis.
Rui K; Zhang Z; Tian J; Lin X; Wang X; Ma J; Tang X; Xu H; Lu L; Wang S
Cell Mol Immunol; 2016 May; 13(3):401-8. PubMed ID: 26388237
[TBL] [Abstract][Full Text] [Related]
20. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
